Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index; 4 of the 24 sources its claims cite were checked for support.

Methicillin-Resistant Staphylococcus aureus Nasal Carriage among Injection Drug Users: Six Years Later

Open access
Al-Rawahi, G. N., Schreader, A. G., Porter, S. D., Roscoe, D. L., Gustafson, R., Bryce, E. A. · 2008 · Journal of Clinical Microbiology

Abstract

A survey in 2000 to detect MRSA colonization in Vancouver DTES injection drug users revealed an MRSA nasal colonization incidence of 7.4%. In this 2006 follow-up study of 301 IDUs, S. aureus was isolated from 119 (39.5%). Overall MRSA carriage rate was 18.6%. USA-300 (CMRSA-10) accounted for 75% of all MRSA isolates, replacing USA-500 (CMRSA-5, 25%). 97.6% of USA-300 contained PVL. Antibiograms showed 100% vs 7.1% susceptibility to TMP-SMX and 54.8% vs 7.1% to clindamycin.

Overview

CoChat Summary

TL;DR

This follow-up point-prevalence survey found MRSA nasal colonization among Vancouver downtown east side injection drug users rose from 7.4% in 2000 to 18.6% in 2006, with USA-300 replacing USA-500. USA-300 isolates were mostly PVL-positive and all were susceptible to trimethoprim-sulfamethoxazole.

Key findings

  • *S. aureus* nasal carriage was 119/301 (39.5%) in 2006 versus 81/299 (27.1%) in 2000 (P = 0.001); overall MRSA colonization was 18.6% versus 7.4% (P = 0.0001). Among 122 isolates, 66 (54.1%) were MSSA and 56 (45.9%) were MRSA.
  • PFGE typing showed USA-300 (CMRSA-10) accounted for 42/56 (75%) MRSA isolates and USA-500 (CMRSA-5) for 14/56 (25%); in 2000, USA-500 accounted for 22/22 (100%). PVL was present in 41/42 (97.6%) USA-300 isolates and 0 USA-500 isolates.
  • USA-300 versus USA-500 susceptibility was 100% versus 7.1% for TMP-SMX (P = 0.0001), 95.2% versus 0% for tetracycline (P = 0.0001), and 54.8% versus 7.1% for clindamycin (P = 0.002).
  • Risk factors for MRSA versus MSSA colonization were not significantly different: antibiotic use 85.7% versus 69.7% (P = 0.05) and hospitalization 26.8% versus 15.2% (P = 0.12); no differences were noted between USA-300 and USA-500 for hospitalization, antibiotic use, or travel.

Methods

  • Opportunistic point-prevalence study in the downtown east side of Vancouver, British Columbia, Canada, from 1 April to 1 May 2006; 429 participants were interviewed, and 301 met inclusion criteria and consented to a nasal swab. Eligible participants had injected drugs within the preceding year.
  • Nasal swabs were cultured for *S. aureus*; MRSA screening used cefoxitin disks, with PCR confirmation of *mecA* and *nuc*. Isolates underwent PFGE after SmaI digestion, PVL gene testing, and disk diffusion susceptibility testing.
  • Associations were tested with Fisher’s exact test, with significance at P < 0.05.

Limitations

  • The authors note that the less stringent definition of prior hospitalization within a 3-month period may have obscured risk-factor associations, and that the relative contribution of community versus healthcare transmission will remain unknown until more definitive epidemiological surveys are performed.
  • Evident from the text: this was an opportunistic point-prevalence study recruited from social and health service centers, so the sample may not represent all injection drug users; risk factors relied on a brief anonymous questionnaire; and a single nasal swab may underestimate carriage.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1128/jcm.01596-07

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

4 Valid · 0 Not valid · 9 Not checked · 28 Own results and interpretations

18 more claims

Create a free account to see all 41 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 5
  • The quote only partly states this claim. 5
  • It may state two separate claims as one. 11

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 20 references

Research works printed but not linked: 1

  1. Analysis. United Nations Office on Drugs and Crime 2004 vol. 1

Cited by

See all 57

Metadata

Authors
Al-Rawahi, G. N., Schreader, A. G., Porter, S. D., Roscoe, D. L., Gustafson, R., & Bryce, E. A.
Affiliations
  • Department of Pathology and Laboratory Medicine
  • University of British Columbia (CA)
  • Vancouver General Hospital (CA)
  • Vancouver Coastal Health (CA)
Corresponding author
Bryce, E. A.
Venue
Journal of Clinical Microbiology
Published
2008-02
Volume
46
Issue
2
Pages
477-479
ISSN
  • 0095-1137 (ISSN-L)
  • 1098-660X
OpenAlex
W2164601804
Cited by
57
References
20
Citations by year
2025: 3 · 2024: 2 · 2021: 4 · 2020: 2 · 2019: 2 · 2018: 4 · 2017: 1 · 2016: 2 · 2015: 4 · 2014: 4 · 2013: 4 · 2012: 6
FWCI
3.57
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Journal of Clinical Microbiology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Vancouver Coastal Health Research Institute
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
  • Health Sciences › Medicine › Infectious Diseases › Otolaryngology and Infectious Diseases
Keywords
methicillin-resistant Staphylococcus aureus, nasal carriage, people who inject drugs, community-acquired MRSA, Panton-Valentine leukocidin, mecA gene, antimicrobial susceptibility, trimethoprim-sulfamethoxazole, clindamycin resistance, strain replacement, risk factors for colonization
MeSH terms
Bacterial Proteins, Bacterial Toxins, Canada, Carrier State, DNA, Bacterial, Exotoxins, Genotype, Humans, Leukocidins, Male, Microbial Sensitivity Tests, Nasal Cavity, Staphylococcal Infections, Staphylococcus aureus, Bacterial Typing Techniques, Substance Abuse, Intravenous, Methicillin Resistance, DNA Fingerprinting, Electrophoresis, Gel, Pulsed-Field, Molecular Epidemiology, Penicillin-Binding Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Methicillin-Resistant Staphylococcus aureus Nasal Carriage among Injection Drug Users: Six Years Later. https://app.cochat.ai/papers/10.1128/jcm.01596-07
The paper
Al-Rawahi, G. N., Schreader, A. G., Porter, S. D., Roscoe, D. L., Gustafson, R., & Bryce, E. A. (2008). Methicillin-Resistant Staphylococcus aureus Nasal Carriage among Injection Drug Users: Six Years Later. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01596-07

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.